Randomized multicenter phase II pilot study to evaluate the efficacy and safety of treatment with FOLFIRI-aflibercept compared with an initial treatment with FOLFIRI-afliercept (for 6 cycles) followed by maintenance with 5FU-aflibercept in elderly patients with metastatic colorectal cancer (mCRC) after of failure of an oxaliplatin regimen
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: DIGESTIVE TUMORS TREATMENT GROUP (TTD)
- Phase: II
- Execution start: 21/06/2017
- End of execution: 30/07/2021
- IP: ENCARNA GONZALEZ FLORES